This inventor holds 2 USPTO granted patents. Top assignees: Bioleaders Corporation, Chosun University, Korea Research Institute of Bioscience and Biotechnology. Active years: 2007-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 25 
1 out of 120 
1 out of 335 
Years Active: 2007-2011
Title: Innovations of Dong-Gun Lee in Peptide Antibiotics
Introduction
Dong-Gun Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of peptide antibiotics. With a total of 2 patents, his work focuses on innovative methods for expressing these antibiotics on microbial surfaces.
Latest Patents
One of Dong-Gun Lee's latest patents is titled "Surface expression method of peptides P5 and Anal3 using the gene encoding poly-gamma-glutamate synthetase." This invention relates to a method for expressing peptide antibiotics P5 and Anal3, which exhibit amphiphilicity and demonstrate antibacterial, antifungal, and anticancer activities. The method utilizes a vector containing outer membrane protein genes derived from specific strains involved in the synthesis of poly-gamma-glutamate. The invention also encompasses lactic acid-forming bacteria that express these peptide antibiotics on their surfaces. This innovative approach allows for the mass production of peptide antibiotics without the need for purification processes, showcasing high industrial applicability. Furthermore, the method can be extended to other peptide antibiotics beyond P5 and Anal3.
Career Highlights
Throughout his career, Dong-Gun Lee has worked with notable organizations such as Bioleaders Corporation and the Korea Research Institute of Bioscience and Biotechnology. His experience in these institutions has contributed to his expertise in biotechnology and antibiotic development.
Collaborations
Dong-Gun Lee has collaborated with several professionals in his field, including Moon-Hee Sung and Seung-Pyo Hong. These collaborations have likely enhanced his research and development efforts in peptide antibiotics.
Conclusion
Dong-Gun Lee's innovative work in the field of peptide antibiotics demonstrates his commitment to advancing biotechnology. His patents reflect significant advancements that have the potential for high industrial applicability.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile